Publication | Closed Access

Efficacy and safety of intermittent, long-term, concomitant dobutamine and levosimendan infusions in severe heart failure refractory to dobutamine alone

Heart FailureCardiac AnaesthesiaCardiogenic ShockCardiovascular DiseaseConcomitant DobutamineCardiovascular PharmacologyLevosimendan InfusionsPharmacotherapyCardiac CareMedicineCardiologyAnesthesiology